SCHEMBL10067671

SCHEMBL10067671

COCc1nc2cc3c(cc2c(=O)[nH]1)C(C)CC3

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 4/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
PARP14 Q460N5 3/20 0.37
THRB P10828 1/20 0.37
HCAR2 Q8TDS4 1/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPK1 P28482 2/20 0.35
CASP1 P29466 1/20 0.35
HBB P68871 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
RAB9A P51151 1/20 0.34
USP2 O75604 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10074706 0.85 PARP1 (0.37) ALDH1A1KDM4EGAATDP1PARP14
SCHEMBL13842610 0.79 QTRT1 (0.41)
SCHEMBL1343569 0.76 PARP1 (0.40) ALDH1A1KDM4ETDP1PARP14MAPT
SCHEMBL1038155 0.76 PARP1 (0.40) ALDH1A1KDM4ETDP1PARP14MAPT
SCHEMBL10209684 0.75 SMN1; SMN2 (0.35) KDM4EGAATDP1PARP14THRB
SCHEMBL10209809 0.73 TNKS2 (0.45) KDM4EGAATDP1PARP14THRB
SCHEMBL15180115 0.73 TNKS2 (0.45) KDM4EGAATDP1PARP14THRB
SCHEMBL989215 0.73 MAPT (0.38) ALDH1A1KDM4EPARP14MAPTPOLB
SCHEMBL24792433 0.72 KDM4E (0.67) ALDH1A1KDM4EGAATDP1THRB
SCHEMBL988272 0.72 DHFR (0.37) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2293807-B1 CYCLOPENTA[G]QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF RHEUMATOID ARTHRITIS OR ACUTE MYELOID LEUKAEMIA BTG INT LTD (GB) 2012-05-09 EP disclosed
US-7250511-B2 Process for the preparation of cyclopenta[g]quinazoline derivatives BTG INTERNATIONAL LIMITED (GB) 2007-07-31 US disclosed